Literature DB >> 28831612

Blood urea nitrogen to serum creatinine ratio as a prognostic factor in diarrhea-associated hemolytic uremic syndrome: a validation study.

Alejandro Balestracci1, Luciana Meni Battaglia2, Ismael Toledo2, Sandra Mariel Martin2, Caupolican Alvarado2.   

Abstract

Identifying those children with complicated forms of diarrhea-associated hemolytic uremic syndrome (D+HUS) on admission can optimize their management. Recently, the blood urea nitrogen to serum creatinine ratio (BCR) at admission has been proposed as a novel and accurate predictor of complicated clinical outcome in D+HUS; therefore, we performed this retrospective study aimed to validate such observation in a larger series of patients. A complicated course was defined as developing one or more of the following: severe neurological or bowel injury, pancreatitis, cardiac or pulmonary involvement, hemodynamic instability, hemorrhage, and death. Data from 161 children were reviewed, 50 of them with a complicated disease including five deaths. Those with worse evolution presented a lower admission BCR than those with good outcome (22.5 vs. 30.8; p = 0.005). BCR at admission showed a limited ability to identify children at risk of a complicated course, with an AUC of 0.63 (95% CI 0.58-0.71) and an optimal cutoff point of ≤ 26.7, which achieves a sensitivity of 70% (95% CI 55.2-81.7) and a specificity of 56.7% (95% CI 47-66).
CONCLUSION: In this validation study, the BCR at admission provided a limited value to predict severe forms of D+HUS. What is Known: • BCR at admission has been proposed as an accurate predictor of complicated clinical course in children with D+HUS. What is New: • In a larger series of children with D+HUS, we were unable to confirm the usefulness of the admission BCR to early identify those at risk of complicated forms of the disease. • Further research is warranted to improve the optimal detection of these high-risk patients.

Entities:  

Keywords:  BUN to serum creatinine ratio; Complicated course; Diarrhea; Hemolytic uremic syndrome

Mesh:

Substances:

Year:  2017        PMID: 28831612     DOI: 10.1007/s00431-017-2999-4

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  19 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

2.  Dehydration at admission increased the need for dialysis in hemolytic uremic syndrome children.

Authors:  Alejandro Balestracci; Sandra Mariel Martin; Ismael Toledo; Caupolican Alvarado; Raquel Eva Wainsztein
Journal:  Pediatr Nephrol       Date:  2012-04-03       Impact factor: 3.714

3.  The fallacy of the BUN:creatinine ratio in critically ill patients.

Authors:  Jean-Sebastien Rachoin; Ralph Daher; Charles Moussallem; Barry Milcarek; Krystal Hunter; Christa Schorr; Mariam Abboud; Patricia Henry; Lawrence S Weisberg
Journal:  Nephrol Dial Transplant       Date:  2011-12-29       Impact factor: 5.992

4.  Hemorrhagic colitis in postdiarrheal hemolytic uremic syndrome: retrospective analysis of 54 children.

Authors:  Ricardo C Rahman; Carlos J Cobeñas; Ricardo Drut; Oscar R Amoreo; Javier D Ruscasso; Ana P Spizzirri; Angela Del C Suarez; Javier H Zalba; Celia Ferrari; Marcela C Gatti
Journal:  Pediatr Nephrol       Date:  2011-08-02       Impact factor: 3.714

5.  Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome.

Authors:  Sylvie Nathanson; Thérésa Kwon; Monique Elmaleh; Marina Charbit; Emma Allain Launay; Jérôme Harambat; Muriel Brun; Bruno Ranchin; Flavio Bandin; Sylvie Cloarec; Guylhene Bourdat-Michel; Christine Piètrement; Gérard Champion; Tim Ulinski; Georges Deschênes
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-24       Impact factor: 8.237

6.  Shiga toxin 1 causes direct renal injury in rats.

Authors:  Elise T Yamamoto; Masashi Mizuno; Kiyotaka Nishikawa; Shinobu Miyazawa; Lianshan Zhang; Seiichi Matsuo; Yasuhiro Natori
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

7.  Blood urea nitrogen/creatinine ratio identifies a high-risk but potentially reversible form of renal dysfunction in patients with decompensated heart failure.

Authors:  Meredith A Brisco; Steven G Coca; Jennifer Chen; Anjali Tiku Owens; Brian D McCauley; Stephen E Kimmel; Jeffrey M Testani
Journal:  Circ Heart Fail       Date:  2013-01-16       Impact factor: 8.790

8.  Laboratory predictors of acute dialysis in hemolytic uremic syndrome.

Authors:  Alejandro Balestracci; Sandra Mariel Martin; Ismael Toledo; Caupolican Alvarado; Raquel Eva Wainsztein
Journal:  Pediatr Int       Date:  2014-03-06       Impact factor: 1.524

9.  Nonsteroidal anti-inflammatory drugs are an important cause of acute kidney injury in children.

Authors:  Jason M Misurac; Chad A Knoderer; Jeffrey D Leiser; Corina Nailescu; Amy C Wilson; Sharon P Andreoli
Journal:  J Pediatr       Date:  2013-01-26       Impact factor: 4.406

10.  Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure.

Authors:  Stefan Porubsky; Giuseppina Federico; Johannes Müthing; Richard Jennemann; Norbert Gretz; Stefan Büttner; Nicholas Obermüller; Oliver Jung; Ingeborg A Hauser; Elisabeth Gröne; Helmut Geiger; Hermann-Josef Gröne; Christoph Betz
Journal:  J Pathol       Date:  2014-07-25       Impact factor: 7.996

View more
  5 in total

1.  Comment to: "A simple prognostic index for Shigatoxin-related hemolytic uremic syndrome at onset: data from the ItalKid-HUS network" by Ardissino et al. Eur J Pediatr. 2018 Aug 10. doi: 10.1007/s00431-018-3198-7.

Authors:  Alejandro Balestracci; Luciana Meni Battaglia; Ismael Toledo; Sandra Mariel Martin; Caupolican Alvarado
Journal:  Eur J Pediatr       Date:  2018-09-07       Impact factor: 3.183

2.  C3 levels and acute outcomes in Shiga toxin-related hemolytic uremic syndrome.

Authors:  Alejandro Balestracci; Luciana Meni Bataglia; Ismael Toledo; Laura Beaudoin; Caupolican Alvarado
Journal:  Pediatr Nephrol       Date:  2019-09-02       Impact factor: 3.714

3.  Rasburicase in hemolytic uremic syndrome related to Shiga toxin-producing Escherichia coli: a report of nine cases.

Authors:  Alejandro Balestracci; Luciana Meni Battaglia; Sandra Mariel Martin; Ismael Toledo
Journal:  Pediatr Nephrol       Date:  2020-03-09       Impact factor: 3.714

4.  Complement activation is associated with more severe course of diarrhea-associated hemolytic uremic syndrome, a preliminary study.

Authors:  Lucia Karnisova; Ondrej Hradsky; Kveta Blahova; Filip Fencl; Zdenek Dolezel; Tomas Zaoral; Jakub Zieg
Journal:  Eur J Pediatr       Date:  2018-09-24       Impact factor: 3.183

5.  Imbalance of Th22/Treg cells causes microinflammation in uremic patients undergoing hemodialysis.

Authors:  Tingting Ren; Jingyuan Xiong; Guangliang Liu; Shaoyong Wang; Zhongqi Tan; Bin Fu; Ruilin Zhang; Xuesong Liao; Qirong Wang; Zonglin Guo
Journal:  Biosci Rep       Date:  2019-10-30       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.